- Home
- GRFS
GRFS
Grifols S.A.
as 04-18-2025 1:37pm EST
| Founded: | 1940 | Country: | Spain |
| Employees: | N/A | City: | N/A |
| Market Cap: | N/A | IPO Year: | 2006 |
| Target Price: | N/A | AVG Volume (30 days): | 1.0M |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.24 | EPS Growth: | 283.33 |
| 52 Week Low/High: | $5.79 - $9.96 | Next Earning Date: | 01-01-0001 |
| Revenue: | $7,467,006,939 | Revenue Growth: | 9.41% |
| Revenue Growth (this year): | 8.45% | Revenue Growth (next year): | 7.08% |
Latest Grifols S.A. News
GRFS Breaking Stock News: Dive into GRFS Ticker-Specific Updates for Smart Investing
Medical Device Network
10 days ago
IBL partners with Grifols to develop biomarker panels for speciality diagnostics
Simply Wall St.
11 days ago
Exploring High Growth Tech Stocks In Europe April 2025
MT Newswires
17 days ago
European Equities Close Lower in Wednesday Trading; Brookfield in Talks Again to Acquire Grifols
MT Newswires
17 days ago
Sector Update: Health Care Stocks Fall Pre-Bell Wednesday
MT Newswires
17 days ago
Market Chatter: Brookfield Resumes Discussions for Potential Grifols Deal
Reuters
17 days ago
Spanish pharma company Grifols' shares up on Brookfield talk
Simply Wall St.
a month ago
High Growth Tech Stocks in Europe for March 2025
MT Newswires
2 months ago
Grifols Aims to Double Revenue Over Next Decade
Compare GRFS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "GRFS Grifols S.A. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.